| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/27/2008 | US7378108 Percutaneous absorption preparation of compound having angiotensin II antagonistic activity |
| 05/27/2008 | US7378104 Delivering substances to invertebrate organisms |
| 05/27/2008 | US7378102 Diclofenac sodium oral pharmaceutical |
| 05/27/2008 | US7378097 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 05/27/2008 | US7378082 Method for treating allergic rhinitis without adverse effects |
| 05/27/2008 | CA2575873A1 Spray mixture for soothing a cow udder |
| 05/27/2008 | CA2455115C Pharmaceutical aerosol formulation |
| 05/27/2008 | CA2438170C Modulated release particles for aerosol delivery |
| 05/27/2008 | CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/27/2008 | CA2345064C Fentanyl composition for the treatment of acute pain |
| 05/27/2008 | CA2319100C Microparticle inhalation formulations |
| 05/27/2008 | CA2264895C Device and method for treating ophthalmic diseases |
| 05/27/2008 | CA2256960C High glycerin containing anti-microbial cleansers |
| 05/27/2008 | CA2127392C Process for producing capsule and capsule obtained thereby |
| 05/22/2008 | WO2008060964A2 Unit dosage package and methods for administering weight loss medications |
| 05/22/2008 | WO2008060963A2 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
| 05/22/2008 | WO2008060934A2 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 05/22/2008 | WO2008060929A1 Punctal plug comprising a water-insoluble polymeric matrix |
| 05/22/2008 | WO2008060890A2 Darusentan oral dosage form |
| 05/22/2008 | WO2008060786A2 Microencapsules containing surface-modified microparticles and methods of forming and using the same |
| 05/22/2008 | WO2008060734A2 Nanoparticle compositions |
| 05/22/2008 | WO2008060575A2 Drug delivery system and method |
| 05/22/2008 | WO2008060515A2 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs |
| 05/22/2008 | WO2008060365A2 A self-gelling tunable drug delivery system |
| 05/22/2008 | WO2008060360A2 Implantable medical device with apertures for delivery of bioactive agents |
| 05/22/2008 | WO2008060359A2 Biodegradable ocular implants and methods for treating ocular conditions |
| 05/22/2008 | WO2008060228A1 Extended release formulations comprising quetipine and methods for their manufacture |
| 05/22/2008 | WO2008060173A2 Procedure and devices for the controlled obtaining of dry saline aerosols with therapeutic effect |
| 05/22/2008 | WO2008060154A1 Capsules from separated polymer solutions |
| 05/22/2008 | WO2008060051A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | WO2008059905A1 Raw material for oral product and oral product using the same |
| 05/22/2008 | WO2008059792A1 Method for production of sustained release tablet |
| 05/22/2008 | WO2008059652A1 Disintegrating agent, and tablet and granule each containing the same |
| 05/22/2008 | WO2008059062A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 05/22/2008 | WO2008059060A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | WO2008059059A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | WO2008058893A1 Edible emulsions with pgpr |
| 05/22/2008 | WO2008058691A2 Powder formulation for inhalation |
| 05/22/2008 | WO2008058654A1 Absorbent composition for surface treatment |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2008058366A1 Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof |
| 05/22/2008 | WO2008041245A3 Injectable depot composition and it's process of preparation |
| 05/22/2008 | WO2008039737A3 A method of administering a film product containing a drug |
| 05/22/2008 | WO2008038007A3 Method of separating carbon nanotubes |
| 05/22/2008 | WO2008037502A3 Olanzapine pharmaceutical composition with anhydrous lactose |
| 05/22/2008 | WO2008033024A3 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 05/22/2008 | WO2008029401B1 Nucleation in liquid, methods of use thereof and methods of generation thereof |
| 05/22/2008 | WO2008029282A3 Aqueous formulation comprising an antitumor agent |
| 05/22/2008 | WO2008017521A3 Compositions with enhanced elasticizing activity |
| 05/22/2008 | WO2008015232A8 Subcutaneous implants releasing an active principle over an extended period of time |
| 05/22/2008 | WO2008008364A3 Enhanced stability phenylephrine liquid compositions |
| 05/22/2008 | WO2008000466A3 Use of an antimicrobial hardening alginate material for the topical treatment of wounds and inflammations in human, dental, and veterinary medicine and for cosmetic purposes |
| 05/22/2008 | WO2007146319A3 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| 05/22/2008 | WO2007141344B1 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 05/22/2008 | WO2007133583A3 Zero-order modified release solid dosage forms |
| 05/22/2008 | WO2007132296B1 Multilayer tablet |
| 05/22/2008 | WO2007130960A3 Stable ophthalmic oil-in-water emulsions with omega-3 fatty acids for alleviating dry eye |
| 05/22/2008 | WO2007128443A3 Spherical or non-spherical microcapsules comprising glp-i peptides, their production and use |
| 05/22/2008 | WO2007127380A3 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 05/22/2008 | WO2007122388A3 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 05/22/2008 | WO2007119249A3 Pharmaceutical compositions of cefixime |
| 05/22/2008 | WO2007108010A3 Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate |
| 05/22/2008 | US20080119826 Continuous Subcutaneous Insulin Infusion Therapy |
| 05/22/2008 | US20080119572 Treatment for basal cell carcinoma |
| 05/22/2008 | US20080119569 Polymer-based sustained release device |
| 05/22/2008 | US20080119567 Geranium oil and extracts from roots of Sophora; H. pylori infection; citronellol; sodium/potassium ATPase inhibitors; cardiovascular disorders; gastric ulcers |
| 05/22/2008 | US20080119564 evalbuterol L-hemitartrate, a crystal form; administered using a metered dose inhaler containg an aerosol in crystal form to effect bronchodilation; reproducible; stablility; storage stability; aerodynamically favorable shape, such as a fiber, to reach lung depth; antiagglomerants |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
| 05/22/2008 | US20080119494 Drug-enhanced adhesion prevention |
| 05/22/2008 | US20080119449 Reducing the risk of osteoporotic bone fractures; kit |
| 05/22/2008 | US20080119391 Comprising hydrolyzed gelatin/tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery |
| 05/22/2008 | US20080118571 Modified release analgesic suspensions |
| 05/22/2008 | US20080118570 Polymer coated drug-ion exchange resins and methods |
| 05/22/2008 | US20080118569 Biocompatible, hydrophilic, non-toxic microspheres associated with stem cells and a biocompatible carrier and are not capable of being displaced, or eliminated by the lymphatic system; tissue-targeted therapy, tissue repair |
| 05/22/2008 | US20080118568 For perfumes, silicones, waxes, flavors, vitamins and fabric softening agents; cosmetics; laundering; improved delivery efficiency |
| 05/22/2008 | US20080118567 Medicaments for Chemotherapeutic Treatment of Disease |
| 05/22/2008 | US20080118566 Micronizing mometasone furoate and lactose particles, wherein at least one has a convertible amorphous content, homogenizing, agglomerating, converting the amorphous to crystalline |
| 05/22/2008 | US20080118565 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 05/22/2008 | US20080118564 Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance |
| 05/22/2008 | US20080118563 Preparation of Chitin and Derivatives Thereof For Cosmetic and Therapeutic Use |
| 05/22/2008 | US20080118561 Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition |
| 05/22/2008 | US20080118560 Spray congealed 5-amido-7-benzyl(oxy or amino)imidazo[1,2-a]pyridines, at least one each of hydrophilic and hydrophobic matrix formers; antisecretory agents with improved water solubility, bioavailability and pharmacokinetics |
| 05/22/2008 | US20080118559 Pharmaceutical Composition Containing an Anti-Nucleating Agent |
| 05/22/2008 | US20080118558 2-Isopropyl-5-methyl-cyclohexanecarboxylic acid [2'-hydroxy-2'-(3''-hydroxy-phenyl)-ethyl]-N-methyl-amide; topical analgesics and antipruritic and antitussive agents for disorders caused by kidney failure or cholestatic jaundice |
| 05/22/2008 | US20080118557 For once-a-day oral administration; improved solubility and bioavailability; side effect reduction |
| 05/22/2008 | US20080118556 Tablets or capsules with an outer controlled release layer preferably comprising methacrylate-based Eudragits"; one inner portion is quick release and the other portion is sustained release |
| 05/22/2008 | US20080118555 A lactose-based excipient and a pharmaceutically acceptable filler; basic salt-free; storage stability |
| 05/22/2008 | US20080118554 Controlled release forms of fexofenadine and pseudoephedrine; once-daily or twice-daily dosages |
| 05/22/2008 | US20080118552 Finely Divided Composition Containing Poorly Water Soluble Substance |
| 05/22/2008 | US20080118551 Denatured human albumin biomaterial as dressing for burns and wounds of skin |
| 05/22/2008 | US20080118549 Sustained release intraocular implants and methods for treating ocular vasculopathies |
| 05/22/2008 | US20080118548 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist, such as brimonidine, associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents; glaucoma |
| 05/22/2008 | US20080118547 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents |
| 05/22/2008 | US20080118545 Sustained-Release Composition, Process for Producing the Same and Use of the Same |
| 05/22/2008 | US20080118539 Anti-biocontaminant products and processes for making the same |
| 05/22/2008 | US20080118500 Nanosphere contains phospholipid/cholesterol particle comprising vesicle, and agent-carrying component capable of forming complex with therapeutic agent via electrostatic charge-charge interaction or hydrophobic-hydrophobic interaction; cyclodextrins |